Inositol phospholipid pathway inhibitors and regulators Inositol phospholipid pathway inhibitors and regulators

Bibliography

• HARDIE DG: Biochemical messenger. Hormones, neurotransmitters and growth factors. Champman & Hall, London (1991).
   Google Scholar
• BERRIDGE MJ: Inositol trisphosphate and calcium signalling. Nature (1993) 361 :315–325.
   PubMed Web of Science ®Google Scholar
• •Well documented review of the biochemical aspects of inotiol phosphate studies.
   Google Scholar
• STREB H, IRVINE RF, BERRIDGE MJ: Release of Ca2+ from nonmitochondrial intracellular store in pancreatic acinar cells by inosito1-1,4,5-trisphosphate. Nature (1983) 306:67–69.
   PubMed Web of Science ®Google Scholar
• •The first important report of the role of I(1,4,5)P3 in Ca2+ release.
   Google Scholar
• HALLCHER LM, SHERMAN WR: The effects of lithium ionand other agents on the activity of myo-in o sitol-1 - -p h o sp h atas e from bovine brain. J. Biol. Chem. (1980) 255:10896–10901.
   PubMed Web of Science ®Google Scholar
• NAHORSKI SR, POTTER BVL: Molecular recognition ofinositol polyphosphates by intracellular receptors and metabolic enzymes. Trends Pharmacol Sci. (1989) 10:139–144.
   PubMedGoogle Scholar
• CHI TH, CRABTREE GR: Inositol phosphates in the nucleus. Science (2000) 287:1937–1939.
   PubMed Web of Science ®Google Scholar
• ••Describes new potential roles of inositol polyphosphates interms of nuclear functions.
   Google Scholar
• FUKUDA M, MIKOSHIBA K: The function of inositol polyphosphate binding proteins. Bioessay (1997) 19:593–603.
   PubMed Web of Science ®Google Scholar
• SHAMSUDDIN AM: Metabolism and cellular functions of IP6. AntiCancer Res. (1999) 19:3733–3736.
   PubMedGoogle Scholar
• FRUMAN DA, MEYERS RE, CANTLEY LC: Phosphoinosi-tide kinases. Ann. Rev. Biochem. (1998) 67:481–507.
   PubMed Web of Science ®Google Scholar
• FRANKE TF, TANG SI, CHAN TO: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell (1995) 81:727–736.
   PubMed Web of Science ®Google Scholar
• THOMAS JR, DWEK RA, RADEMACHER TW: Structure, biosynthesis and function of glycosylphosphatidyli-nositols. Biochemistry (1990) 29:5413–5422.
   PubMed Web of Science ®Google Scholar
• GAULTON GN, PRATT JC: Glycosylated phosphatidyli-nositol molecules as second messengers. Semin. Immunol. (1994) 6:97–104.
   PubMedGoogle Scholar
• EARDLEY DD, KOSHLAND ME: Glycosylphosphatidyli-nositol: a candidate system for interleukin-2 signal transduction. Science (1991) 251:78–81.
   PubMed Web of Science ®Google Scholar
• CHAN BL, CHAO MV, SALTIEL AR: Nerve growth factor stimulates the hydrolysis of glycosylphosphatidyli-nositol in PC-12 cells: a mechanism of protein kinase C regulation. Proc. Nati Acad. Sci. USA (1989) 86:1756–1760.
   PubMedGoogle Scholar
• ALEMANY S, MATO JM, SKALFORS P: Phospho-dephospho-control by insulin is mimicked by a phospho-oligosaccharide in adipocytes. Nature (1987) 330:77–79.
   PubMed Web of Science ®Google Scholar
• RHEE SG, BAE YS: Regulation of phosphoinositide-specific phospholipaseCisozymes. J. Biol. Chem. (1997) 272: 15045–15048.
   PubMed Web of Science ®Google Scholar
• BAE YS, CANTLEY LG, CHEN CS, KIM SR, KWON KS, RHEESG: Activation of phospholipase C-7 by phosphatidyli-nositol 3,4,5-trisphosphate. J. Biol. Chem. (1998) 273: 4465–4469.
   PubMed Web of Science ®Google Scholar
• FALASCA M, LOGAN SK, LEHTO VP, BACCANTE G, LEMMON MA, SCHLESSINGER J: Activation of phospholi-pase C-7 by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J. (1998) 17:414–422.
   PubMed Web of Science ®Google Scholar
• SCHARENGERG AM, KINET JP: PtdIn s-3,4,5 -P3: a regula-tory nexus between tyrosine kinases and sustained calcium signals. Cell (1998) 94:5–8.
   PubMedGoogle Scholar
• FERGUSON KM, LEMMON MA, SCHLESSINGER J, SIGLER PB: Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain. Cell (1995) 83:1037–1046.
   PubMedGoogle Scholar
• FRUMAN DA, RAMEH LE, CANTLEY LC: Phosphoinosi-tide binding domains: embracing 3-phosphate. Cell (1999) 97:817–820.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review for the function of 3-phosphate containing inositides and the protein structure of 3-phosphoinositide binding motifs.
   Google Scholar
• BERRIGE MJ, BOOTMAN MD, LIPP P: Calcium -a life and death signal. Nature (1998) 395:645–648.
   PubMedGoogle Scholar
• POTTER BVL, LAMPE D: Chemistry of inositol lipid-mediated cellular signalling. Angew Chem. Int. EdN. Engl. (1995) 34: 1933–1972.
   Google Scholar
• •Well documented review of the synthesis and medicinal chemistry of inositol phosphates and their analogues.
   Google Scholar
• MICHELANGELI F, MEZNA M, TOVEY S, SAYERS LG: Pharmacological modulators of the inositol 1,4,5-trisphosphate receptor. Neuropharmacology (1995) 34:1111–1122.
   PubMedGoogle Scholar
• WILCOX RA, PRIMROSE WU, NAHORSKI SR, CHALLISS RA:New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor. Trends Pharmacol. Sci. (1998) 19:467–475.
   PubMed Web of Science ®Google Scholar
• WORLEY PF, BARABAN JM, SUPATTAPONE S, WILSON VS,SNYDER SH: Characterization of inositol trisphosphate receptor binding in brain. Regulation by pH and calcium. J. Biol. Chem. (1987) 262:12132–12136.
   PubMed Web of Science ®Google Scholar
• KRAUSE KH, SIMMERMAN HKB, JONES LR, CAMPBELL KP:Sequence similarity of calreticulin with a Ca2tbinding protein that co-purifies with an Ins(1,4,5)P3-sensitive Ca2±store in HL-60 cells. Biochem. J. (1990) 270:545–548.
   PubMedGoogle Scholar
• DASSO LL, TAYLOR CW: Heparin and other p oly anion suncouple alpha 1-adrenoceptors from G-proteins. Biochem. J. (1991) 280:791–795.
   PubMed Web of Science ®Google Scholar
• BEZPROZVANNY I, ONDRIAS K, KAFTAN E, STOYANOVSKY DA, EHRLICH BE: Activation of the calcium release channel (ryanodine receptor) by heparin and other polyanions is calcium dependent. Mol. Biol. Cell (1993) 4:347–352.
   PubMed Web of Science ®Google Scholar
• BROWN GR, SAYERS LG, KIRK CJ, MICHEL RH, MICHELANGELI F: The opening of the inositol 1,4,5 -trisphosphate-sensitive Ca2+ channel in rat cerebellum is inhibited by caffeine. Biochem. j (1992) 282:309–312.
   PubMedGoogle Scholar
• MARKS AR: Cardiac intracellular calcium release channels:role in heart failure. Circ. Res. (2000) 87:8–11.
   PubMed Web of Science ®Google Scholar
• PATEL S, JOSEPH SK, THOMAS AP: Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium (1999) 25:247–264.
   PubMed Web of Science ®Google Scholar
• SUDHOF TC, NEWTON CL, ARCHER BT, USHKARYOV YA,MIGNERY GA: Structure of a novel IP3R. EMBO J. (1991) 10:3199–3206.
   PubMedGoogle Scholar
• NEWTON CL, MIGNERY GA, SUDHOF TC: Co-expressionin vertebrate tissues and cell lines of multiple IP3R receptors with distinct affinities for IP3. J. Biol. Chem. (1994) 269:28613–28619.
   PubMedGoogle Scholar
• YONESHIMA H, MIYAWAKI A, MICHIKAWA T, FURUICHI T, MIKOSHIBA K: Ca2+ differentially regulates the ligand-affinity states of Type 1 and Type 3 IP3R. Biochem. J. (1997) 322:591–596.
   PubMedGoogle Scholar
• KUNO M, GARDNER P: Ion channels activated by inositol 1,4,5-trisphosphate in plasma membrane of human T-lymphocytes. Nature (1987) 326:301–304.
   PubMed Web of Science ®Google Scholar
• KHAN AA, STEINER JP, KLEIN MG, SCHNEIDER MF, SNYDER SH: IP3R localization to plasma membrane of T cells and cocapping with the T cell receptor. Science (1992) 257:815–818.
   PubMed Web of Science ®Google Scholar
• NICOTERA P, ORRENIUS S, NILSSON N, BERGEGREN P:An inositol 1,4,5-trisphosphate-sensitive Ca2+ pool in liver nuclei. Proc. Natl. Acad. Sci. USA (1990) 87:6858–6862.
   PubMed Web of Science ®Google Scholar
• STEHNO-BITTEL L, LUCKHOFF A, CLAPHAM DE: Calcium release from the nucleus by IP3R channels. Neuron (1995) 14:163–167.
   PubMedGoogle Scholar
• TASKER PN, TAYLOR CW, NIXON GF: Expression and distribution of IP3R subtypes in proliferating vascular smooth muscle cells. Biochem. Biophys. Res. Commun. (2000) 273:907–912.
   PubMedGoogle Scholar
• VANHAESEBROECK B, LEEVERS SJ, PNAYOTOU G, WATERFIELD MD: Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. ScL (1997) 2 2:267–272.
   Google Scholar
• TOKER A, Cantley LC: Signalling through the lipidproducts of phosphoinositide-3-0H kinase. Nature (1997) 387:673–676.
   PubMedGoogle Scholar
• POWIS G, BONJOUKLIAN R, BERGGREN MM et al: Wortmannin, a potent and selective inhibitor of phosph atidylin o sito1-3 -kin ase. Cancer Res. (1994) 54:2419–2423.
   PubMed Web of Science ®Google Scholar
• NAKANISHI S, CATT JK, BALLA T: A wortmannin-sensitive phosphatidylinositol 4-kinase that regulates hormone-sensitive pools of inositolphospholipids. Proc. Natl. Acad. ScL USA (1995) 92:5317–5321.
   PubMedGoogle Scholar
• HOPKIN K: A surprising function for the PTEN tumor suppressor. Science (1998) 282:1029–1030.
   Google Scholar
• ••Describes a novel function of PTEN, a known tumoursuppressor, as a counterpart of PI3K.
   Google Scholar
• BARALDI E, CARUGO KD, HYVONEN M et al: Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate. Structure Fold. Des. (1999) 7:449–460.
   Google Scholar
• MISRA S, HURLEY JH: Crystal structure of a phosphati-dylinositol 3-phosphate-specific membrane-targeting motif, the FYVE domain of Vps27p. Cell (1999) 97:657–666.
   PubMed Web of Science ®Google Scholar
• •Describes the structure of an inositol phosphate-binding FYVE domain.
   Google Scholar
• MAO Y, NICKITENKO A, DUAN X et al.: Crystal structure the VHS and FYVEtandem domains of Hrs, a protein involved in membrane trafficking and signal transduction. Cell (2000) 100: 447–456.
   PubMedGoogle Scholar
• ••Provides an alternative structural model of the inositolphosphate-binding FYVE domain.
   Google Scholar
• WOSCHOLSKI R, PARKER PJ: Inositol lipid 5-ph osphatases-traffic signals and signal traffic. Trends Biochem. ScL (1997) 22:427–431.
   PubMed Web of Science ®Google Scholar
• HALLCHER LM, SHERMAN WR: The effects of lithium ionand other agents on the activity of myo-inosito1-1-phosphatase from bovine brain. J. Biol. Chem. (1980) 255:10896–10901.
   PubMed Web of Science ®Google Scholar
• JOHNSON EC, GRAY-KELLER MP, O'DAY PM: Rescue ofexcitation by inositol following Utinduced block in Limulus ventral photoreceptors. Vis. NeuroscL (1998) 15:105–112.
   PubMedGoogle Scholar
• COLODNY L, HOFFMAN RL: Inositol-clinical applica-tions for exogenous use. Ahern. Med. Rev. (1998) 3:432–447.
   PubMedGoogle Scholar
• COHEN H, KOTLER M, KAPLAN Z et al.: Inositol hasbehavioral effects with adaptation after chronic administration. J. Neural Transm. (1997) 152:1084–1086.
   Google Scholar
• BENJAMIN J, LEVINE J, FUX M et al.: Double-blind,placebo-controlled, crossover trial of in ositol treatment for panic disorder. Am. J. Psychiatry (1995) 152:1084–1086.
   PubMed Web of Science ®Google Scholar
• Inostiol Phosphates and Derivatives. ACS Symposium Series 463. Reitz AB (Ed.) (1990).
   Google Scholar
• CHANG YT: Divergent synthesis of all possible regioi-somers of myo-inositol phosphates and their biochemical applications [PhD Thesis]. POSTECH, Korea (1997).
   Google Scholar
• XIE W, KAETZEL MA, BRUZIK KS et al.: Inositol3,4,5,6-tetrakisphosphate inhibits the calmodulin-dependent protein kinase II-activated chloride conductance in T84 colonic epithelial cells. j Biol. Chem. (1996) 271:14092–14097.
   PubMed Web of Science ®Google Scholar
• THELEN M, WYMANN MP, LANGEN H: Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes. Proc. Natl. Acad. ScL USA (1994) 91:4960–4964.
   PubMed Web of Science ®Google Scholar